We’ve joined forces with Kalms Group to help medtech and life sciences businesses expand in the three big global markets of Asia, Europe and North America.
While we specialise in driving companies’ growth in the four biggest East Asian economies of China, Japan, Korea and Taiwan, Kalms Consulting helps firms expand in Europe and North America.
Together, we’re now able to support medtech and life sciences companies’ expansion across all these major markets - providing regulatory advice, market analysis, reimbursement and in-country business development programmes.
Gaining access to Asia, Europe and North America is a primary goal for many medtech and life science companies seeking significantly to increase revenues and company valuations. But market entry and reimbursement are complex in these advanced healthcare sectors. A market entry strategy that’s precisely adapted to the requirements of local healthcare systems can deliver significant gains, while ‘going it alone’ without in-country guidance can lead to costly mistakes.
Our clients in the healthcare and life science ecosystems range from startups to multinationals looking to expand in East Asia. We combine a deep knowledge of the region’s regulatory environment with expertise in assessing market opportunities, developing channels, driving sales, facilitating discussions with KOLs and finding manufacturing and logistics partners. We also help clients, when they’re ready, set up a permanent presence in Asia through a subsidiary, partnership or acquisition.
We’ve worked widely across IVD reagents, medical devices and instruments, R&D tools, assays, software, pharma and more.
Our recent work has included helping Spanish biotech firm BioSystems set up in China, and German precision medicine company Molecular Health develop its business across Japan, South Korea and Taiwan, including deals with a large Korean hospital and a major Korean lab.
Kalms Consulting provides expert, hands-on guidance for medical devices, diagnostics, biotech, health IT and other healthcare companies. It supports them by applying its expertise in the European and North American healthcare sectors, acting as a gateway to two of the world’s largest medical technology markets.
Marco Kalms and his team have more than 200 years’ collective experience in Europe and North America. They offer support in market access, health economics, reimbursement, regulatory matters, quality issues, compliance, business development, sales strategy and fulfillment.
Within Europe, the company’s Kalms Operations subsidiary offers third party logistics (3PL) services, from a single delivery of goods to frequent shipments. It considers all regulations required by local and statutory authorities and follows ISO 13485:2016, while its customer service agents speak multiple languages to enhance the customer experience.
The company’s clients range from early-stage university projects to innovative, fast-growing startups and global medtech corporations.
For queries about expanding in East Asia, please contact Graham Barker from Intralink at graham.barker@intralinkgroup.com.
For enquiries about expanding in Europe or North America, contact Dr Stephan Binder from the Kalms Group at sbinder@kalmsconsulting.com.